Mechanistic investigation of thermosensitive liposome immunogenicity and understanding the drivers for circulation half-life: A polyethylene glycol versus 1,2-dipalmitoyl-sn-glycero-3-phosphodiglycerol study-Reference-Cited by-同舟云学术

Mechanistic investigation of thermosensitive liposome immunogenicity and understanding the drivers for circulation half-life: A polyethylene glycol versus 1,2-dipalmitoyl-sn-glycero-3-phosphodiglycerol study

Published:2021-05 Issue: Volume:333 Page:1-15
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Lokerse Wouter J.M.,Lazarian Artur,Kleinhempel Alisa,Petrini Matteo,Schwarz Patricia,Hossann Martin,Holdt Lesca M.,Mailänder Volker,Lindner Lars H.

Funder

Bundesministerium für Bildung und Forschung

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference95 articles.

1. Novel approaches to treatment of hepatocellular carcinoma and hepatic metastases using thermal ablation and thermosensitive liposomes;Dewhirst;Surg. Oncol. Clin. N. Am.,2013

2. To heat or not to heat: challenges with clinical translation of thermosensitive liposomes;Dou;J. Control. Release,2017

3. Thermosensitive liposomal drug delivery systems: state of the art review;Kneidl;Int. J. Nanomedicine,2014

4. Thermosensitive liposomes for localized delivery and triggered release of chemotherapy;Ta;J. Control. Release,2013

5. Chemical components for the design of temperature-responsive vesicles as cancer therapeutics;Al-Ahmady;Chem. Rev.,2016

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomedicine Tumor Targeting;Advanced Materials;2024-04-12

2. Advances and applications of nanoparticles in cancer therapy;MedComm – Oncology;2024-03

3. Polyethylene glycol-stabilized cationic liposome encapsulating glucosamine sulfate: A promising nanoformulation for osteoarthritis therapy;AIP Advances;2024-02-01

4. Recent Advances in Metal-Hydride-Based Disease Treatment;ACS Applied Materials & Interfaces;2024-01-24

5. Liposomal Drug Delivery Systems for Cancer Therapy: The Rotterdam Experience;Pharmaceutics;2022-10-11